October 25, 2024
TOPLINE: Clinicians should consider zinc deficiency in premature infants having an erythematous, scaly, sharply demarcated rash that does not respond to treatments for the most likely […]
October 25, 2024
TOPLINE: Landiolol reduces and maintains heart rate for 24 hours without increasing the need for vasopressors in patients with septic shock and persistent tachycardia. METHODOLOGY: Researchers […]
October 25, 2024
TOPLINE: For patients with metabolic dysfunction–associated steatotic liver disease (MASLD) and diabetes, treatment with a glucagon-like peptide 1 receptor agonist (GLP-1 RA) may protect against progression […]
October 25, 2024
TOPLINE: Older non-Hispanic Black adults with breast cancer are less likely to receive guideline-concordant care and timely treatment than non-Hispanic White adults, according to findings from […]
October 25, 2024
TOPLINE: High-intensity exercise suppresses ghrelin levels more than moderate-intensity exercise, leading to a greater reduction in hunger. This effect may be more pronounced in women than […]
October 24, 2024
TOPLINE: Increases in prescriptions for both glucagon-like peptide 1 receptor agonists (GLP-1 RAs) and sodium-glucose cotransporter 2 (SGLT2) inhibitors were observed in patients with type 1 […]
October 24, 2024
TOPLINE: A recent study found that long-term exposure to fine particulate matter ≤ 2.5 μm (PM2.5) is associated with an increased risk for breast cancer, with […]
October 24, 2024
TOPLINE: A 48-week oral semaglutide treatment regimen for type 2 diabetes (T2D) reduces weight and improves liver steatosis, liver stiffness, and liver enzyme levels in patients […]
October 24, 2024
TOPLINE: The use of a levonorgestrel-releasing intrauterine system (LNG-IUS) is associated with an increased risk for breast cancer. An analysis by Danish researchers found 14 extra […]